Here are five details:
1. During the second quarter, the company experienced a 27.7 percent increase in revenue to $15.1 million year-over-year.
2. U.S. revenue for the quarter was $11.5 million, a 24.6 percent increase year-over-year, while international revenue was $3.6 million, a 38.7 percent increase year-over-year.
3. OrthoPediatrics’ trauma and deformity segment generated $9.9 million in revenue, a 25.3 percent increase year-over-year. The company’s scoliosis segment earned $4.9 million in revenue, a 42.7 percent increase year-over-year.
4. The company recorded $11.3 million in gross profit for the quarter, a 29.4 percent increase year-over-year. OrthoPediatrics’ total operating expenses were $13.4 million, a 42.6 percent increase year-over-year.
5. By the end of the year, OrthoPediatrics’ expects its revenue growth to range between 23 percent to 24 percent year-over-year. Prior guidance put revenue growth at 22 percent.
To view the full financial report, click here.
More articles on devices and implants:
Xtant Medical net sales decrease 12.6% in Q2: 5 things to know
Mazor Robotics, Zimmer Biomet, NuVasive & more: 11 device company key notes
ORHub names interim CFO & 5 more mid-year updates
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
